TERT-BUTYL 6,7-DIHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-CARBOXYLATE, 95.0%, 25g

2,6-Difluoro-4-methoxybenzoic acid, 95.0%, 250mg

2-(4-Acetamidophenoxy)-N,N,N-trimethylethanaminium bromide, 95.0%, 1g

5-Iodoquinoline, 98%, 100g

2-(2-Fluorophenoxy)propanehydrazide, 97%, 100mg

6-(aminomethyl)-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-5-one hydrochloride, 95.0%, 500mg

2,3-Dihydro-1H-pyrrolo[3,4-c]pyridine hydrochloride, 97.0%, 50mg

Vasos de muestra con cierre de rosca sin graduación, sin área de rotulación, 30 ml, Estéril, 500 Unidad(es)

N-(2-Hydroxyphenyl)methanesulfonamide, 95.0%, 1g

4-{6-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-1,3-benzodiazol-2-yl}phenol trihydrochloride, 98%, 1g

4'-Chloro-N-methylformanilide>98.0%(GC)25g

(S)-1,2-Diphenylethanamine hydrochloride, 98%, 250mg

3-Methoxy-4-nitro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g